Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Nonavalent HPV Vaccine in Healthy Chinese Women
NCT05694728Phase 2Completed
- Sponsor
- Beijing Health Guard Biotechnology Inc.
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of KLWS-V502 in human papillomavirus infection, sponsored by Beijing Health Guard Biotechnology Inc.. Started May 2020; status: completed.
02
Drugs
KLWS-V502
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT05694728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05694728.